Sentry BioPharma Services is a leading service provider for pharmaceutical companies needing to diversify their critical drug safety stocks, thereby reducing their risk of drug shortages brought on by unforeseen calamities.
“In the aftermath of the devastating earthquake and tsunami on March 11, 2011, our company entered into numerous agreements with Japanese pharmaceutical manufacturers,” stated Tim Mitchell, Sentry’s President. “In support of their risk mitigation programs, companies divided their critical drug supplies between their facilities and Sentry’s central Indiana U.S. GMP facility”.
April 2016 Earthquake area: Traced from a report of The Geospatial Information Authority of Japan.
The article below is provided for information purposes.
Plants shut down after quake, fueling economic fears
Apr. 16, 2016 – 06:10AM JST
Some of Japan’s biggest firms including Sony and Toyota shut down operations in southern Japan Friday after the region’s deadly earthquake…
Sentry provides GMP validated temperature product management and global distribution of high value drug products, from API to finished vaccines. Sentry’s validated temperatures range from +15°C to -90°C with multiple temperature set points in between.